Intravascular innate immune cells reprogrammed via intravenous nanoparticles to promote functional recovery after spinal cord injury

Medicine and Dentistry

• Nanoparticle 100%
• Injury 83%
• Immunocompetent Cell 66%
• Spinal Cord Injury 50%
• Serositis 33%
• Risk-Benefit Ratio 33%
• Axon 33%
• Gene Expression 16%
• Cells 16%
• Gene 16%
• Phenotype 16%
• Tissues 16%
• Scar Formation 16%
• Regeneration 16%
• Monocyte 16%
• Microenvironment 16%
• Biodistribution 16%
• Paralysis 16%
• Neutrophil 16%
• Myelination 16%
• Macrophage Polarization 16%
• Gene Function 16%
• Polyglactin 16%
• Methylprednisolone 16%

Pharmacology, Toxicology and Pharmaceutical Science

• Injury 83%
• Spinal Cord Injury 50%
• Inflammation 16%
• Inflammatory Disease 16%
• Biodistribution 16%
• Scar Formation 16%
• Paralysis 16%
• Methylprednisolone 16%
• Polyglactin 16%

Neuroscience

• Spinal Cord Injury 50%
• Axon 33%
• Phenotype 16%
• Gene Expression 16%
• Gene 16%
• Reprogramming 16%
• Monocyte 16%
• Myelinogenesis 16%
• Gene Function 16%
• Methylprednisolone 16%